Grifols and Beckman Coulter Enter into an Exclusive Distribution Agreement


12.06.2017


Barcelona, June 12, 2017- Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), one of the world's leading producers of plasma-derived medicines and a leader in the development of innovative diagnostic solutions, and Beckman Coulter Inc., a leading provider of innovative, efficient and reliable diagnostics solutions, have entered into an exclusive, long-term agreement for the global distribution of Grifols' hemostasis instruments, reagents and consumables.

"Grifols continues to execute its strategy in growing the Specialty Diagnostics line. Our hemostasis product line complements Beckman Coulter's broad portfolio of products and services for the core laboratory," said Carsten Schroeder, Grifols President of Diagnostic Commercial Operations.

"Beckman Coulter's long-term partnership with Grifols expands our extensive diagnostic product offering and further supports our position as a partner of choice with hospitals and clinical laboratories across the world," stated Arnd Kaldowski, President of Beckman Coulter Diagnostics.

"Grifols' hemostasis product line, focused on reliability and efficiency, combined with our global distribution network, automation leadership and clinical informatics solutions for the core laboratory, provide our customers with even more solutions to deliver better patient care," added Kevin Chance, President of Products and Services for Beckman Coulter Diagnostics.

"We are extremely excited about the collaboration with Beckman Coulter. The agreement leverages Grifols' strength in manufacturing reliable instruments and reagents with that of Beckman Coulter's commercial strength," added Oriol Duñach, Grifols President of Diagnostic Industrial Division.

Beckman Coulter and Grifols anticipate first commercializing systems under this distribution agreement in Europe in early 2018.

About Beckman Coulter Inc.

Beckman Coulter Diagnostics helps healthcare and laboratory professionals provide better patient care by delivering the accurate diagnostic information they need, when they need it. For more than 80 years, Beckman Coulter has been the partner of choice for healthcare organizations. The company's scalable instruments, comprehensive diagnostic tests and business management services are trusted by hospitals, laboratories and other critical care settings around the world. We share in our customers' mission toward continuous improvement and quality patient care because we believe when efficiency and clinical outcomes are improved, patients benefit and we can move healthcare forward for every person. For more information, visit www.beckmancoulter.com.